Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement

Area of Science:

• Nephrology
• Critical Care Medicine
• Biomedical Engineering

Background:

• Citrate anticoagulation is standard for continuous renal replacement therapy (CRRT) since 2012.
• A major drawback of citrate is the requirement for calcium replacement and strict calcium level monitoring.
• Heparin is an alternative but carries bleeding risks.

Purpose of the Study:

• To investigate a novel CRRT anticoagulation method eliminating the need for separate calcium replacement.
• To assess the safety and efficacy of maintaining stable total calcium and low ionized calcium in the extracorporeal circuit.

Main Methods:

• A prospective, nonrandomized pilot study involving five acute renal failure patients.
• Citrate and calcium were incorporated into all CRRT solutions.
• Systemic and extracorporeal circuit electrolyte levels, including ionized calcium, were rigorously monitored.

Main Results:

• The new method achieved effective anticoagulation with postfilter ionized calcium levels <0.5 mmol/L.
• No filter clotting or increased filter pressures were observed.
• Systemic electrolyte and acid-base parameters remained stable; no calcium replacement was required.

Conclusions:

• Regional citrate anticoagulation can be performed during CRRT without separate calcium infusion.
• This innovative approach simplifies CRRT management by eliminating calcium replacement needs.
• Further studies are warranted to validate this promising anticoagulation strategy.